The Missouri Department of Mental Health, Division of Behavioral Health, was awarded a $79,042,881 State Opioid Response (SOR) Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under CFDA 93.788. This 3-year federal grant, effective September 30, 2024, will fund a comprehensive set of services to address the opioid abuse crisis in Missouri. Key activities include expanding access to medication-assisted treatment, implementing prevention and harm reduction...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $238,107,340 Project Grant (CFDA 93.243 - Substance Abuse and Mental Health Services Projects of Regional and National Significance) to the Massachusetts Department of Public Health (MDPH) for the Massachusetts State Opioid Response (SOR) Program. This program aims to address the opioid crisis in Massachusetts by increasing access to medication-assisted treatment, and supporting the continuum of prevention, harm...
The U.S. Department of Health and Human Services, through the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded a $45,830,769 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Oregon Health Authority (OHA) for the "SOR 4 - The Oregon State Opioid Response (SOR) 4 Grant." The grant will fund a comprehensive effort to address substance use disorders, overdose prevention,...
The New Jersey Department of Human Services (NJ DHS) was awarded a $206,364,729 Project Grant by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The goals of the NJ State Opioid Response (NJ-SOR) project are to: 1) increase access to medication for opioid use disorder (MOUD); 2) support the continuum of prevention, harm reduction, treatment, and...
The South Carolina State Opioid Response Project (SC SOR PROJECT), funded by a $56,394,492 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA), aims to address the opioid and stimulant use disorder crisis in South Carolina through comprehensive prevention, treatment, harm reduction, and recovery support services. The project will leverage community partnerships and evidence-based strategies to reduce substance use and improve public health outcomes...
This federal Project Grant award of $75,500,157, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid State Targeted Response (Opioid STR) grant program (CFDA 93.788), aims to address the opioid overdose crisis in Washington, D.C. The grant, titled "DCOR 4 - The District of Columbia's Opioid Response 4 (DCOR 4) Initiative," will focus on increasing access to medication for opioid use disorder (MOUD), reducing unmet treatment needs, and...
The Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $183,098,460 Project Grant under the Opioid State Targeted Response (Opioid STR) Program (CFDA 93.788) to the West Virginia Department of Human Services (WVDHS) for the West Virginia State Opioid Response (SOR) Grant. This grant will fund the expansion of evidence-based prevention, early intervention, treatment, and recovery management activities for opioid use disorder (OUD)...
This $86,879,418 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will support the Georgia State Opioid Response (SOR) IV Project. The project aims to expand and sustain opioid use disorder (OUD) treatment, recovery, and prevention services in high-need areas of Georgia. Key activities include: Providing OUD treatment and...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $23,505,387 State Opioid Response (SOR) grant (CFDA 93.243) to the Idaho Department of Health & Welfare's Financial Services Division. This 3-year project grant, effective September 30, 2024, will enhance Idaho's SOR program to increase access to opioid and stimulant use disorder services, expand community recovery support, and reduce opioid/stimulant-related deaths. Key services include providing 1,500...
This $32,106,465 Project Grant was awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant supports the Utah State Opioid Response (UT SOR4) initiative, which aims to prevent and reduce opioid and stimulant use, expand access to harm reduction and treatment services, and promote recovery support for individuals and families in Utah. The...
The Maryland State Opioid Response IV (SOR IV) Initiative is a $159,454,968 Project Grant award from the U.S. Department of Health and Human Services (HHS) Substance Abuse and Mental Health Services Administration (SAMHSA). The grant, authorized under CFDA 93.788 Opioid STR, aims to increase access to and enhance the reach and capacity of prevention, treatment, and recovery support services for individuals with opioid or stimulant use disorders in Maryland.
The key products and services funded through this award include expanding medication-assisted treatment for opioid use disorders, increasing evidence-based treatment and recovery services, distributing naloxone to high-risk populations, expanding harm reduction and public awareness efforts, implementing trauma-informed practices, and enhancing data collection and analysis across the state's SUD/OUD continuum of care. The grant period runs from September 30, 2024 to September 29, 2027, with the goal of serving 888,900 individuals through prevention, treatment, and recovery services by the end of the project. This grant supports a range of sub-awards to local health departments, non-profit organizations, and community-based groups across Maryland to deliver these critical public health interventions.